Tilray, Inc.
Tilray, Inc. is listed today as Tilray: market value, financials and filings are on its company page.
Funding rounds
1 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Feb 2018 | $50 M | No. 1 | $50 to $250 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
As the listed company Tilray, its revenue in fiscal 2026 came from these product and service lines: Adult-use Cannabis Products $236.35 million (26%), International Cannabis Products $84.91 million (9%), Medical Cannabis Products $23.73 million (3%), Wholesale Cannabis Products $7.32 million (1%).
Annual report (SEC XBRL) · May 2026
Tilray, Inc. chose not to state its revenue in its newest notice of a funding round (Feb 2018).
SEC Form D · Feb 2018
The industry group it chose in its notices: Other.
SEC Form D · Feb 2018
Products and services#
No products or services of Tilray, Inc. are on record.
Investors#
No investor of Tilray, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 12 investors.
Largest shareholders today
Institutions holding Tilray shares, as of Sep 30, 2026.
- Tidal Investments LLC$10 M1.84%
- Susquehanna International Group, LLP$5 M0.89%
- UBS Group AG$5 M0.85%
- Citadel Advisors LLC$4 M0.64%
- Morgan Stanley$4 M0.63%
- MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.$3 M0.51%
- Point72 Asset Management, L.P.$3 M0.50%
- AQR Capital Management LLC$2 M0.31%
- ExodusPoint Capital Management, LP$2 M0.31%
- BlackRock, Inc.$2 M0.29%
- Bank Of America Corp /de/$1 M0.26%
- Vanguard Portfolio Management LLC$1 M0.26%
- State Street Corp$1 M0.25%
- Goldman Sachs Group Inc$1 M0.24%
- Swiss National Bank$1 M0.17%
Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Brendan Kennedy | Executive officer | Feb 2018 |
| Brendan Kennedy | Director | Feb 2018 |
| Michael Auerbach | Director | Feb 2018 |
About
Pharmaceutical and cannabis company.
Went public since 2018. Its SEC number is that of a company listed on a stock exchange.